Santhiravel Sarusha, Dave Deepika, Shahidi Fereidoon
Memorial University of Newfoundland, Canada.
Marine Institute of Memorial University of Newfoundland, Canada.
Pharmacol Rev. 2024 Oct 7. doi: 10.1124/pharmrev.124.001227.
The oceans are a rich source of a myriad of structurally different and unique natural products that are mainly found in invertebrates with potential applications in different disciplines. Microbial infection and cancer are the leading causes of death worldwide. Discovery of new sources of therapy for microbial infections is an urgent requirement due to the emergence of pathogenic microorganisms that are resistant to existing therapies. Marine bioactives have demonstrated to be promising sources for the discovery and development of novel antimicrobial and anticancer compounds. Several marine compounds are confirmed to have antibacterial effects and most marine-based antifungal compounds are cytotoxic. Numerous antitumor marine natural products, derived mainly from sponges or molluscs, and also bryozoans and cyanobacteria, exhibit potent antimitotic activity. In addition, marine biodiversity offers some possible leads or new drugs to treat human immunodeficiency virus (HIV). A majority of marine derived drugs are currently in clinical trials or under preclinical evaluation. Furthermore, marine-based drugs, approved by the US Food and Drug Administration (FDA) are available in the market. This review summarizes the sources, mechanisms of action and potential utilization of marine natural products such as peptides, alkaloids, polyketides, polyphenols, terpenoids and sterols as antifungal, antibacterial, antiviral, and anticancer compounds. Utilization of marine bioactives as natural health products leads to crucial advancement in providing dietary supplements, nutraceuticals, functional foods and pharmaceuticals. Their myriad of application promotes health and plays a role in disease risk reduction. Therapeutic potential of potent compounds from marine organisms and use of their bioactives have promising medicinal value for preventing ailments and advancing pharmaceutical and nutraceutical industries. Their utilization benefits human health globally and contributes to the conservation of marine ecosystem in a transformative / sustainable approach.
海洋是无数结构各异且独特的天然产物的丰富来源,这些产物主要存在于无脊椎动物中,在不同学科领域具有潜在应用价值。微生物感染和癌症是全球主要的死因。由于出现了对现有疗法具有抗性的致病微生物,因此迫切需要发现新的微生物感染治疗来源。海洋生物活性物质已被证明是发现和开发新型抗菌和抗癌化合物的有前景的来源。几种海洋化合物已被证实具有抗菌作用,并且大多数基于海洋的抗真菌化合物具有细胞毒性。许多主要源自海绵或软体动物,以及苔藓虫和蓝细菌的抗肿瘤海洋天然产物具有强大的抗有丝分裂活性。此外,海洋生物多样性为治疗人类免疫缺陷病毒(HIV)提供了一些可能的线索或新药。目前,大多数源自海洋的药物正在进行临床试验或临床前评估。此外,已获得美国食品药品监督管理局(FDA)批准的基于海洋的药物已投放市场。本综述总结了海洋天然产物如肽、生物碱、聚酮化合物、多酚、萜类化合物和甾醇作为抗真菌、抗菌、抗病毒和抗癌化合物的来源、作用机制和潜在用途。将海洋生物活性物质用作天然健康产品在提供膳食补充剂、营养保健品、功能性食品和药品方面取得了关键进展。它们的众多应用促进健康并在降低疾病风险方面发挥作用。海洋生物中强效化合物的治疗潜力及其生物活性物质的使用对于预防疾病以及推动制药和营养保健品行业具有广阔的药用价值。它们的利用有益于全球人类健康,并以变革性/可持续的方式促进海洋生态系统的保护。